Felipe Cava, MIMS group leader and associate professor at the Department of Molecular Biology, Umeå University, recently published a new scientific article on cell-wall stapling, a unique technique for cell-wall peptidoglycan modification in bacteria. This strategy provides a novel way to chemically lace the bacterial wall. This work is the result of a successful collaboration between the Cava lab in Umeå and several partners in the United States (University of Massachusetts, Harvard Medical School, Stanford University, Dana-Farber Cancer Institute). The study was led by Felipe Cava and M. Sloan Siegrist, assistant professor at the Department of Microbiology, University of Massachusetts.
Access to the article: https://pubmed.ncbi.nlm.nih.gov/33238158/
Continue reading to see contact and related information.